Literature DB >> 10372884

Acanthamoeba keratitis with live isolates treated with cryosurgery and fluconazole.

S P Amoils1, C Heney.   

Abstract

PURPOSE: To report live, active trophozoites in an eye with Acanthamoeba keratitis that resembled Acanthamoeba polyphagia in the anterior chamber fluid obtained by transcorneal tap.
METHOD: After prediagnostic therapy had failed, we performed cryosurgery to break the corneal cell walls and treated the patient with oral fluconazole.
RESULTS: The condition resolved after 8 weeks of oral fluconazole therapy. Residual leukoma was treated by corneal graft.
CONCLUSION: Live, motile Acanthamoeba can be isolated from an anterior chamber tap; combination therapy with oral fluconazole after corneal cryosurgery may be effective.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10372884     DOI: 10.1016/s0002-9394(98)00426-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

Review 1.  Microbial cytochromes P450: biodiversity and biotechnology. Where do cytochromes P450 come from, what do they do and what can they do for us?

Authors:  Steven L Kelly; Diane E Kelly
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-06       Impact factor: 6.237

2.  [Acanthamoeba keratitis].

Authors:  N Szentmáry; L Daas; P Matoula; S Goebels; B Seitz
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

3.  Azole Antifungal Agents To Treat the Human Pathogens Acanthamoeba castellanii and Acanthamoeba polyphaga through Inhibition of Sterol 14α-Demethylase (CYP51).

Authors:  David C Lamb; Andrew G S Warrilow; Nicola J Rolley; Josie E Parker; W David Nes; Stephen N Smith; Diane E Kelly; Steven L Kelly
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

Review 4.  CYP51 as drug targets for fungi and protozoan parasites: past, present and future.

Authors:  Galina I Lepesheva; Laura Friggeri; Michael R Waterman
Journal:  Parasitology       Date:  2018-04-12       Impact factor: 3.234

5.  Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs.

Authors:  Brian Shing; Mina Balen; James H McKerrow; Anjan Debnath
Journal:  Expert Rev Anti Infect Ther       Date:  2021-05-19       Impact factor: 5.091

Review 6.  Acanthamoeba keratitis - Clinical signs, differential diagnosis and treatment.

Authors:  Nóra Szentmáry; Loay Daas; Lei Shi; Kornelia Lenke Laurik; Sabine Lepper; Georgia Milioti; Berthold Seitz
Journal:  J Curr Ophthalmol       Date:  2018-10-19

Review 7.  Drug Discovery against Acanthamoeba Infections: Present Knowledge and Unmet Needs.

Authors:  Hany M Elsheikha; Ruqaiyyah Siddiqui; Naveed Ahmed Khan
Journal:  Pathogens       Date:  2020-05-22

8.  The Effect of Anti-Amoebic Agents and Ce6-PDT on Acanthamoeba castellanii Trophozoites and Cysts, In Vitro.

Authors:  Lei Shi; Vithusan Muthukumar; Tanja Stachon; Lorenz Latta; Mohamed Ibrahem Elhawy; Gubesh Gunaratnam; Erika Orosz; Berthold Seitz; Albrecht F Kiderlen; Markus Bischoff; Nóra Szentmáry
Journal:  Transl Vis Sci Technol       Date:  2020-11-23       Impact factor: 3.283

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.